Insmed IncorporatedINSMNASDAQ
Loading
R&D Expense Growth TrendStable
Percentile Rank36
3Y CAGR-14.2%
5Y CAGR-5.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-14.2%/yr
vs +9.0%/yr prior
5Y CAGR
-5.1%/yr
Recent deceleration
Acceleration
-23.3pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 28.87% |
| 2024 | 4.79% |
| 2023 | 43.64% |
| 2022 | 45.75% |
| 2021 | 50.56% |
| 2020 | 37.54% |
| 2019 | -9.34% |
| 2018 | 32.38% |
| 2017 | -10.57% |
| 2016 | 65.22% |